Title
Summary
Landmark study demonstrates effectiveness of hESC in repairing heart
Scientists have demonstrated that human embryonic stem cell (hESC)-derived cardiomyocytes improv...[more]
Enrollment starts for STAPLE-2 trial
Drs Michael G Douglas and John P Henretta, of Carolina Vascular, a division of Asheville Radiolo...[more]
First human implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
AtriCure has announced that its Cosgrove-Gillinov Left Atrial Appendage Occlusion System was suc...[more]
First patient receive Sutura's SuperStitch EL to close PFO
The first patient to received a SuperStitch EL (developed by Sutura) to close a patent foramen o...[more]
Enrollment completed in ExoSeal vascular closure trial
Cordis Corporation, a Johnson & Johnson subsidiary, announced the completion of patient enroll...[more]
TUCSON trial to assess SonoLysis + tPA therapy in acute ischaemic stroke
ImaRx Therapeutics has received approval from the Data and Safety Monitoring Board (DSMB) to pro...[more]
Lombard receives IDE for Pythagoras clinical trial
Lombard Medical Technologies has received full supplemental Investigational Device Exception (ID...[more]
SONOMA-3 trial recruits first patient
Nuvelo has enrolled the first patient in the SONOMA-3 (Speedy Opening of Non-functional and Occl...[more]
Medtronic invests initial US$3.75 million in NanoCor
NanoCor Therapeutics has announced that Medtronic has invested US$3.75 million in the company. N...[more]
BioVascular merges with Revitus
BioVascular, a company focused on developing therapies targeting platelet-mediated diseases, has...[more]
Teleflex to acquire Arrow International for US$2.0 billion
Teleflex has agreed to acquire Arrow International, a provider of catheter-based access and ther...[more]
Merck completes NovaCardia purchase
Merck & Co has successfully completed the acquisition of NovaCardia, a privately held clinical-s...[more]
The Amplatzer Muscular Ventricular Septal Defect Occluder receives FDA approval
AGA Medical has received FDA approval to market the Amplatzer Muscular Ventricular Septal (VSD) ...[more]
Edwards Lifesciences gains CE mark for Sapien Transcatheter Heart Valve
Edwards Lifesciences has received CE mark approval for European commercial sales of its Edwards ...[more]
CE mark granted for C-Port Flex A System
Cardica recently received CE mark approval for the C-Port Flex A Anastomosis System. The C-Port ...[more]
FDA advisory panel to review Medtronic's Endeavor DES
Medtronic announced that a FDA Advisory Panel will review the pre-market approval (PMA) applicat...[more]
Terumo coronary guidewire technology now available in US
Terumo Interventional Systems has announced the launch of its breakthrough Runthrough NS Coronar...[more]
Amplatzer Vascular Plug II approved in US and Europe
AGA Medical has received FDA and European approvals for the Amplatzer Vascular Plug II. The Ampl...[more]
FoxHollow introduces SilverHawk EXL device
FoxHollow Technologies has launched the SilverHawk EXL. The device is designed to increase tissu...[more]
Concentric's Merci L6 Retriever cleared for stroke patients
Concentric Medical has obtained US clearance for its Merci L6 Retriever. This new Retriever join...[more]
FDA clears heparin-bonded endoprosthesis for SFA interventions
The FDA has cleared W L Gore & Associates (Gore) to market its Gore Viabahn Endoprosthesis with ...[more]
If you want more information about the newsletter, including receiving a sample copy, then please e-maill info@cardiovascular-innovations.com